Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with Parkinson's disease based on the Movement Disorder Society's diagnostic criteria.
- People who are older than 45 and younger than 90 years of age.
- People whose Parkinson's disease is rated at Stage 2 or 3 on the Hoehn and Yahr scale, which generally reflects early-to-mid stage disease (confirm with trial site).
- People who speak English.
- People who are able to sign a written consent form before the study begins.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have another neurological condition, or who show neurological signs during a physical examination.
- People who score higher than 11 on the Geriatric Depression Scale, which is a screening tool used to assess depression.
- People who have evidence of a stroke or a growth or mass in the brain, found on a previous CT or MRI scan.
- People who are younger than 45 or older than 90 years old.
- People who do not speak English.
- People who are pregnant, think they may be pregnant, or are trying to become pregnant.
- People who have a pacemaker, lines going into the heart, a medication pump implanted in the body, or any other medically implanted device.
- People who have cochlear (hearing) implants.
- People who are currently taking certain medications that affect brain receptors involved in learning and brain adaptability, including GABAergic drugs, NMDA-receptor antagonists, or similar medications (confirm with trial site).
- People who have non-removable body piercings or foreign objects inside the body.
- People who have metal anywhere in or near the head that could increase the risk of injury during the study (note: braces and dental fillings are not included), such as:
- A deep brain stimulator or vagus nerve stimulator
- Aneurysm clips or coils
- Stents in the neck or brain
- Implanted stimulators
- Electrodes used to monitor brain activity
- Metal implants in the eyes or ears
- Shrapnel or bullet fragments in or near the head
- Facial tattoos made with metallic or magnetic-sensitive ink
- Any other metal devices or objects implanted in or near the head
- People who have any condition that may increase the risk of having a seizure, including:
- A personal or family history of seizures or epilepsy
- Taking prescription medications that lower the threshold for seizures
- A recent history of excessive alcohol consumption
- A history of alcohol addiction or dependence
- A recent history of recreational drug use
- A history of drug addiction or dependence
- People who have been diagnosed with any of the following conditions:
- Stroke, brain haemorrhage, brain tumour, encephalitis, or multiple sclerosis
- Alzheimer's disease
- Attention deficit disorder, schizophrenia, or bipolar disorder
- Normal pressure hydrocephalus or raised pressure inside the skull
- Diabetes requiring insulin treatment
- A serious heart condition or liver disease
- People who have recently experienced jetlag from extended air travel, or who are in a sleep-deprived state.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 734-763-2790
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Participant perception of treatment acceptability; Retention rate; Percentage change in TUG test time to 48 hours and 14 days post-intervention; Net changes in FOG-Q scores at 48 hours and 14 days post-intervention
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.